Metformin-associated lactic acidosis in Sweden 1977–1991
- 1 July 1993
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 44 (6) , 589-591
- https://doi.org/10.1007/bf02440866
Abstract
Since the withdrawal of phenformin in 1978, the use of metformin has increased from 13,500 to 22,00 patient years/year. During the period 1977–91 a total of 18 cases of metformin — associated acidosis was reported, of which 16 had lactic acidosis. The incidence of reported acidosis and lactic acidosis decreased from 1.50 cases per 10,000 patient years in 1977–81 to 0.24 cases per 10,000 patient years 1987–91, probably due to lower doses doses and reduced usage in the very old. All the reports described patients with several other concomitant diseases, mainly cardiovascular and renal, when the acidosis was diagnosed. It is important continuously to re-evaluate metformin therapy and to stop treatment at the onset of impaired renal or cardiovascular function.Keywords
This publication has 11 references indexed in Scilit:
- Role of metformin in treatment of diabetes mellitusDiabetes Care, 1987
- Metformin and glibenclamide: comparative risks.BMJ, 1984
- HYDROXYLATION OF DEBRISOQUINE IN PATIENTS WITH LACTICACIDOSIS AFTER PHENFORMINThe Lancet, 1981
- The mechanism of the acute hypoglycemic action of phenformin (DBI)Metabolism, 1980
- GENETIC IMPAIRMENT OF PHENFORMIN METABOLISMThe Lancet, 1980
- Epidemiology of adverse drug reactions to phenformin and metformin.BMJ, 1978
- Lactic acidosis in biguanide-treated diabeticsDiabetologia, 1978
- Antidiabetic Drugs After the University Group Diabetes Program (UGDP)Annual Review of Pharmacology, 1975
- Biguanides and lactate metabolism: a review.1973
- Effect of Biguanides on Intestinal Absorption of GlucoseDiabetes, 1968